Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study.

Source:http://linkedlifedata.com/resource/pubmed/id/9667667

Download in:

View as

General Info

PMID
9667667